Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome

Kavita Narayan Gaisamudre (Sarwade); Sarika Pralhad Sarwade; Prakash Pralhad Sarwade; Deeksha Singh; K. M. Srinandhinidevi; M. Jansi Rani; Jadhav Kavita; Dipti Hitendra Chirmade

doi:10.55544/jrasb.3.5.4

Authors

Kavita Narayan Gaisamudre (Sarwade) Assistant Professor, Department of Botany, Shriman Bhausaheb Zadbuke Mahavidyalaya, Barshi Tal. Barshi, Dist- Solapur 413 401 Maharashtra, INDIA.
Sarika Pralhad Sarwade Shikshan Maharshi Guruvarya R. G. Shinde Mahavidyalaya, Paranda Dist-Dharashiv (Osmanabad) 413 502, (M.S.) INDIA.
Prakash Pralhad Sarwade Associate Professor and Head, Department of Botany, Shikshan Maharshi Guruvarya R. G. Shinde Mahavidyalaya, Paranda Dist. Dharashiv (Osmanabad) 413 502, (M.S.), INDIA.
Deeksha Singh OBGYN Physiotherapist, Nutritionist, Pelvic Floor Rehab Specialist, Jamia Hamdard University, New Delhi, INDIA.
K. M. Srinandhinidevi Assistant Professor, Department of Zoology, Quaid-e-Millath Government College for Women (Autonomous), Chennai-02, INDIA.
M. Jansi Rani Professor, Department of OBG, Sri Sai Ram Homoeopathic Medical College and Hospital, INDIA.
Jadhav Kavita Junior College Teacher, Shri Dnyaneshwar Mahavidyalaya Newasa District -Ahmednagar Maharashtra, INDIA.
Dipti Hitendra Chirmade Assistant Professor, H.K. College of Pharmacy, Jogeshwari West, Mumbai, INDIA.

DOI:

https://doi.org/10.55544/jrasb.3.5.4

Keywords:

PCOS, Exercise, Hormone, Pathophysiology

Abstract

Numerous reproductive-aged women are impacted by polycystic ovary syndrome (PCOS), an endocrine-gynecology condition. While a risk factor for polycystic ovarian syndrome (PCOS) has been identified, much about the disease's origins and pathophysiology is still up in the air. We searched PubMed and ClinicalTrials.gov extensively for results pertaining to the utilisation of repurposed pharmaceuticals in order to acquire information about the causes and treatments of polycystic ovarian syndrome (PCOS) for this study. We looked at everything that could be causing polycystic ovary syndrome. In addition, the data for both the most commonly prescribed PCOS medications and those that have been repurposed are summarised in the tables. Insulin resistance, inflammation, environmental toxicants, epigenetics, oxidative stress, hyperandrogenism, stress, and nutrition were all part of the internal components that were reviewed. Altering one's way of life and making use of complementary and alternative medicine is often the first line of defence against illness for many people. There is some evidence that certain medications and supplements may be effective in treating polycystic ovarian syndrome (PCOS). These chemicals include mucolytic medicines, thiazolidinediones, sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, 3-hydroxy-3-methyl-3-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors, and glucose-like peptide-1 receptor agonists.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Deans, R. (2019). Polycystic ovary syndrome in adolescence. Medical Sciences, 7(10), 101.

Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019). Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. Journal of the Endocrine Society, 3(8), 1545-1573.

Bednarska, S., & Siejka, A. (2017). The pathogenesis and treatment of polycystic ovary syndrome: What's new?. Advances in Clinical and Experimental Medicine, 26(2).

Ganie, M. A., Vasudevan, V., Wani, I. A., Baba, M. S., Arif, T., & Rashid, A. (2019). Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian Journal of Medical Research, 150(4), 333-344.

Glueck, C. J., & Goldenberg, N. (2019). Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism, 92, 108-120.

Damone, A. L., Joham, A. E., Loxton, D., Earnest, A., Teede, H. J., & Moran, L. J. (2019). Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychological medicine, 49(9), 1510-1520.

Hochberg, Z. E., Feil, R., Constancia, M., Fraga, M., Junien, C., Carel, J. C., ... & Albertsson-Wikland, K. (2011). Child health, developmental plasticity, and epigenetic programming. Endocrine reviews, 32(2), 159-224.

Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology, 14(5), 270-284.

Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S., ... & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature reviews Disease primers, 2(1), 1-18.

Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019). Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. Journal of the Endocrine Society, 3(8), 1545–1573. https://doi.org/10.1210/js.2019-00078

Dennett, C. C., & Simon, J. (2015). The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes spectrum : a publication of the American Diabetes Association, 28(2), 116–120. https://doi.org/10.2337/diaspect.28.2.116

Sirmans, S. M., & Pate, K. A. (2013). Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical epidemiology, 1-13.

Cinar, N., Kizilarslanoglu, M. C., Harmanci, A., Aksoy, D. Y., Bozdag, G., Demir, B., & Yildiz, B. O. (2011). Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Human Reproduction, 26(12), 3339-3345.

Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011). Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews endocrinology, 7(4), 219-231.

Diamanti-Kandarakis, E., Kandarakis, H., & Legro, R. S. (2006). The role of genes and environment in the etiology of PCOS. Endocrine, 30, 19-26.

Shannon, M., & Wang, Y. (2012). Polycystic ovary syndrome: a common but often unrecognized condition. Journal of midwifery & women’s health, 57(3), 221-230.

Urbanek, M. (2007). The genetics of the polycystic ovary syndrome. Nature clinical practice Endocrinology & metabolism, 3(2), 103-111.

Marx, T. L., & Mehta, A. E. (2003). Polycystic ovary syndrome: pathogenesis and treatment over the short and long term. Cleveland Clinic journal of medicine, 70(1), 31-45.

STRAUSS III, J. F. (2003). Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Annals of the New York Academy of Sciences, 997(1), 42-48.

Shele, G., Genkil, J., & Speelman, D. (2020). A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome. Journal of functional morphology and kinesiology, 5(2), 35. https://doi.org/10.3390/jfmk5020035

Dos Santos, I. K., Ashe, M. C., Cobucci, R. N., Soares, G. M., de Oliveira Maranhão, T. M., & Dantas, P. M. S. (2020). The effect of exercise as an intervention for women with polycystic ovary syndrome: A systematic review and meta-analysis. Medicine, 99(16), e19644. https://doi.org/10.1097/MD.0000000000019644

Stepto, N. K., Patten, R. K., Tassone, E. C., Misso, M. L., Brennan, L., Boyle, J., Boyle, R. A., Harrison, C. L., Hirschberg, A. L., Marsh, K., Moreno-Asso, A., Redman, L., Thondan, M., Wijeyaratne, C., Teede, H. J., & Moran, L. J. (2019). Exercise Recommendations for Women with Polycystic Ovary Syndrome: Is the Evidence Enough?. Sports medicine (Auckland, N.Z.), 49(8), 1143–1157. https://doi.org/10.1007/s40279-019-01133-6

Patten, R. K., Boyle, R. A., Moholdt, T., Kiel, I., Hopkins, W. G., Harrison, C. L., & Stepto, N. K. (2020). Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis. Frontiers in physiology, 11, 606.

Ribeiro, V. B., Kogure, G. S., Lopes, I. P., Silva, R. C., Pedroso, D. C. C., de Melo, A. S., ... & Dos Reis, R. M. (2020). Effects of continuous and intermittent aerobic physical training on hormonal and metabolic profile, and body composition in women with polycystic ovary syndrome: A randomized controlled trial. Clinical endocrinology, 93(2), 173-186.

Cassidy-Vu, L., Joe, E., & Kirk, J. K. (2016). Role of statin drugs for polycystic ovary syndrome. Journal of family & reproductive health, 10(4), 165.

Brown, A. J., Setji, T. L., Sanders, L. L., Lowry, K. P., Otvos, J. D., Kraus, W. E., & Svetkey, P. L. (2009). Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome. Medicine and science in sports and exercise, 41(3), 497–504. https://doi.org/10.1249/MSS.0b013e31818c6c0c

Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016). The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction, 31(12), 2841-2855.

Tofighi, A., Tartibian, B., Ameri, M. H., Najafi Eliasabad, S., Asemi, A., & Shargh, A. (2010). Effect of aerobic exercise on hormonal level and lipid profile in polycystic ovary syndrome women. Studies in Medical Sciences, 21(4), 332-338.

Cena, H., Chiovato, L., & Nappi, R. E. (2020). Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. The Journal of Clinical Endocrinology & Metabolism, 105(8), e2695-e2709.

Rondanelli, M., Infantino, V., Riva, A., Petrangolini, G., Faliva, M. A., Peroni, G., ... & Perna, S. (2020). Polycystic ovary syndrome management: a review of the possible amazing role of berberine. Archives of gynecology and obstetrics, 301(1), 53-60.